When Glasses Aren’t the Answer: A Quiet Conversation About Macular Degeneration
- simplifeyeoptical
- Feb 2
- 6 min read
A reminder of why eye health matters — especially as we age
I was at an eyewear styling appointment with a client in one of the residences I visit when the client asked if her friend could sit in with us.
She wasn’t there to look at frames.
She wanted to talk about lenses.
She was upset — and scared.
She told me she felt like she was going blind and didn’t know what to do. And she wanted me to make her glasses that would help her see better.
We talked through her vision history, who she’d seen as her ophthalmologist or optometrist, and what she was experiencing day to day. And then I had to say something that never gets easier:
Glasses couldn’t fix what was going on.
I explained that I’m an optician — not an optometrist, not an ophthalmologist, and not a retinal specialist — and that what she was describing needed medical follow-up, not a stronger prescription.
She was likely a candidate for low-vision aids, but before taking that step, she needed to be seen again by her ophthalmologist.
I encouraged her not to let the symptoms slide and to call for another appointment.
Later, when I delivered her friend’s glasses, I learned she had followed through — she’d been seen again and was getting help.
That mattered.
Because moments like that are a reminder of something we don’t talk about enough: vision loss isn’t always about needing glasses — and by the time it feels obvious, something deeper may already be happening.
This post is part of a series called When Glasses Aren’t the Answer — conversations about eye health, vision loss, and why regular eye exams matter just as much as the glasses we wear.
Where AMD fits into this conversation
Age-related macular degeneration (AMD) affects the macula, the small but critical part of the retina responsible for sharp, central vision — the vision we rely on for reading, recognizing faces, and seeing fine detail.
AMD is one of the leading causes of irreversible central vision loss in adults over the age of 50. It affects both men and women, and while researchers continue to explore differences in prevalence, age remains the strongest and most consistent risk factor.
February is recognized as AMD Awareness Month, which makes it a fitting time to talk about how AMD shows up in real life — and why regular eye health exams matter long before glasses stop helping.
One of the challenges with AMD is that it often progresses quietly. Our brains are remarkably good at filling in gaps and adapting — until one day something feels “off,” and it’s hard to know how long it’s been that way.
The steady ground: what still matters most
Before talking about what’s new, it’s important to acknowledge what hasn’t changed — because these foundations still matter deeply.
Regular eye exams and monitoring
Early AMD often causes no noticeable symptoms. Regular eye exams allow subtle changes to be detected and monitored over time — and create a clear baseline if anything shifts.
This is especially important because wet AMD, while less common, requires timely medical treatment to protect vision.
AREDS2: still the gold standard for dry AMD
The AREDS and AREDS2 clinical trials, led by the U.S. National Eye Institute, remain the strongest evidence-based intervention for people with intermediate AMD.
AREDS2 supplements:
do not prevent AMD
do not restore lost vision
can reduce the risk of progression to advanced stages in certain people
They’re not for everyone — but when recommended by an eye care professional, they remain a cornerstone of AMD care.
Wet AMD: medical treatment saves vision
If AMD becomes wet, treatment is managed by a retinal specialist, most often with anti-VEGF injections.
These treatments don’t cure AMD, but they can slow or stop further damage and preserve remaining vision — which is why sudden distortion, dark spots, or rapid changes should always be assessed promptly.
Where things begin to shift: newer approaches for dry AMD
For a long time, conversations about dry AMD ended with monitoring, supplements, and waiting. That landscape is slowly evolving.
In Canada:
In Canada, regulated, clinic-based medical devices are now available to support visual function in people with dry AMD. One example is MacuMira, a Health Canada-approved device designed to stimulate retinal function through a controlled, non-invasive treatment delivered in-office.
These treatments are not cures. They don’t reverse AMD.
But they represent an important shift: dry AMD is no longer viewed as something we can only watch.
In the United States:
In the U.S., the Valeda Light Delivery System (LumiThera) has received FDA authorization for use in dry AMD.
This matters because it clarifies a common misconception:
Therapeutic light is not defined by colour alone.
Medical photobiomodulation systems are defined by specific wavelengths, controlled energy delivery, defined treatment protocols, and clinical evidence — not simply by the presence of “red light.”
Advanced dry AMD: slowing loss, not restoring vision
For people with geographic atrophy, an advanced form of dry AMD, injectable treatments such as Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol) have been approved in the U.S. to slow disease progression.
These treatments do not restore vision — but they represent meaningful progress.
As of now, they are approved in the U.S., with Canadian availability still under review.
Looking ahead: when research feels genuinely hopeful
One of the most fascinating areas of research involves the PRIMA retinal implant — a subretinal photovoltaic “chip” studied in people with advanced dry AMD and geographic atrophy.
Early clinical trials have shown improvements in visual task performance, including letter recognition.
This isn’t everyday care yet — but it’s a reminder of how far AMD research has come from the idea that “nothing can be done.”
What glasses can — and cannot — do
Glasses play an important role — but they aren’t always the first or only answer.
In conditions like AMD, medical care comes first, followed by functional tools such as low-vision aids. Glasses can then support what remains — but they can’t replace care for the underlying disease.
Glasses don’t treat AMD. They don’t stop disease progression. They don’t repair damaged retinal cells.
But they can:
optimize remaining vision
improve contrast and comfort
support daily tasks
reduce visual fatigue
And if better vision is possible — why struggle?
I often compare it to watching a movie on an old tube TV when a high-definition screen is available. You can get by — but once you see the difference, it’s hard to go back.
Living with AMD: practical ways to support your vision
While AMD can change how vision works, small environmental adjustments can make a meaningful difference in comfort and independence.
Light matters
As we age, our eyes need more light — and AMD can amplify that need.
use brighter, evenly distributed lighting
add adjustable task lamps for reading
position light behind and over the shoulder
reduce glare where possible
Contrast often helps more than size
choose high-contrast reading materials — (e.g. black text on a yellow background).
use bold labels on medications
adjust phone and tablet settings for contrast
Magnification — when appropriate
Low-vision aids, from magnifiers to electronic readers, can be incredibly helpful when matched to the right task and stage — which is why proper medical assessment comes first.
Reduce visual clutter
Simplifying spaces and reducing busy patterns can lower visual fatigue and make it easier to find what you’re looking for.
A simple tool worth knowing: the Amsler grid
The Amsler grid is a simple, evidence-based tool used to monitor changes in central vision over time.
Used regularly — one eye at a time — it can help detect:
new distortion
wavy or missing lines
blurred areas
If anything changes, it’s important to contact your eye care provider promptly.
The Amsler grid does not replace eye exams and does not diagnose AMD — think of it as an early warning system, not a final answer.
If AMD runs in your family
AMD can’t always be prevented — but risk can be influenced.
What consistently helps:
regular eye exams
not smoking
UV protection
cardiovascular health
a nutrient-rich diet
appropriate supplementation when indicated
Prevention isn’t about guarantees. It’s about staying engaged with your eye health.
The takeaway
AMD care today is a combination of:
steady, proven foundations
emerging treatments
supportive strategies that protect independence and quality of life
Progress is happening — not loudly, and not all at once — but meaningfully.
And sometimes, the most important step isn’t finding the right pair of glasses — it’s knowing when to pause, ask deeper questions, and make sure the right kind of care is happening first.
Written by Teresa Smith, Registered Optician
Founder of Simplifeye Optical, a mobile optical practice serving Simcoe County and surrounding communities. Teresa works as an optician first and foremost — helping people understand their vision, choose eyewear that fits well and feels right, and recognize when vision changes may need to be assessed beyond glasses.
This article is shared for general information and does not replace advice from an optometrist or ophthalmologist.
